115 related articles for article (PubMed ID: 21839068)
1. Circulating cell-free DNA in plasma of melanoma patients: qualitative and quantitative considerations.
Pinzani P; Salvianti F; Zaccara S; Massi D; De Giorgi V; Pazzagli M; Orlando C
Clin Chim Acta; 2011 Nov; 412(23-24):2141-5. PubMed ID: 21839068
[TBL] [Abstract][Full Text] [Related]
2. Allele specific Taqman-based real-time PCR assay to quantify circulating BRAFV600E mutated DNA in plasma of melanoma patients.
Pinzani P; Salvianti F; Cascella R; Massi D; De Giorgi V; Pazzagli M; Orlando C
Clin Chim Acta; 2010 Sep; 411(17-18):1319-24. PubMed ID: 20576522
[TBL] [Abstract][Full Text] [Related]
3. Circulating plasma DNA as diagnostic biomarker in non-small cell lung cancer.
Paci M; Maramotti S; Bellesia E; Formisano D; Albertazzi L; Ricchetti T; Ferrari G; Annessi V; Lasagni D; Carbonelli C; De Franco S; Brini M; Sgarbi G; Lodi R
Lung Cancer; 2009 Apr; 64(1):92-7. PubMed ID: 18804892
[TBL] [Abstract][Full Text] [Related]
4. Quantification of free circulating DNA as a diagnostic marker in lung cancer.
Sozzi G; Conte D; Leon M; Ciricione R; Roz L; Ratcliffe C; Roz E; Cirenei N; Bellomi M; Pelosi G; Pierotti MA; Pastorino U
J Clin Oncol; 2003 Nov; 21(21):3902-8. PubMed ID: 14507943
[TBL] [Abstract][Full Text] [Related]
5. Multiparametric analysis of cell-free DNA in melanoma patients.
Salvianti F; Pinzani P; Verderio P; Ciniselli CM; Massi D; De Giorgi V; Grazzini M; Pazzagli M; Orlando C
PLoS One; 2012; 7(11):e49843. PubMed ID: 23209607
[TBL] [Abstract][Full Text] [Related]
6. DNA integrity in plasma and serum of patients with malignant and benign diseases.
Holdenrieder S; Burges A; Reich O; Spelsberg FW; Stieber P
Ann N Y Acad Sci; 2008 Aug; 1137():162-70. PubMed ID: 18837942
[TBL] [Abstract][Full Text] [Related]
7. Prediction of breast tumor progression by integrity of free circulating DNA in serum.
Umetani N; Giuliano AE; Hiramatsu SH; Amersi F; Nakagawa T; Martino S; Hoon DS
J Clin Oncol; 2006 Sep; 24(26):4270-6. PubMed ID: 16963729
[TBL] [Abstract][Full Text] [Related]
8. Cell-free DNA concentration and integrity as a screening tool for cancer.
Zaher ER; Anwar MM; Kohail HM; El-Zoghby SM; Abo-El-Eneen MS
Indian J Cancer; 2013; 50(3):175-83. PubMed ID: 24061455
[TBL] [Abstract][Full Text] [Related]
9. Quantification of plasma cell-free DNA in patients with gastric cancer.
Sai S; Ichikawa D; Tomita H; Ikoma D; Tani N; Ikoma H; Kikuchi S; Fujiwara H; Ueda Y; Otsuji E
Anticancer Res; 2007; 27(4C):2747-51. PubMed ID: 17695442
[TBL] [Abstract][Full Text] [Related]
10. Detection of tyrosinase mRNA from the blood of melanoma patients.
Stevens GL; Scheer WD; Levine EA
Cancer Epidemiol Biomarkers Prev; 1996 Apr; 5(4):293-6. PubMed ID: 8722221
[TBL] [Abstract][Full Text] [Related]
11. Circulating cell-free DNA: a promising marker of pathologic tumor response in rectal cancer patients receiving preoperative chemoradiotherapy.
Agostini M; Pucciarelli S; Enzo MV; Del Bianco P; Briarava M; Bedin C; Maretto I; Friso ML; Lonardi S; Mescoli C; Toppan P; Urso E; Nitti D
Ann Surg Oncol; 2011 Sep; 18(9):2461-8. PubMed ID: 21416156
[TBL] [Abstract][Full Text] [Related]
12. Free circulating DNA as possible tumour marker in colorectal cancer.
Boni L; Cassinotti E; Canziani M; Dionigi G; Rovera F; Dionigi R
Surg Oncol; 2007 Dec; 16 Suppl 1():S29-31. PubMed ID: 18024018
[TBL] [Abstract][Full Text] [Related]
13. Quantification of circulating plasma DNA fragments as tumor markers in patients with esophageal cancer.
Tomita H; Ichikawa D; Ikoma D; Sai S; Tani N; Ikoma H; Fujiwara H; Kikuchi S; Okamoto K; Ochiai T; Otsuji E
Anticancer Res; 2007; 27(4C):2737-41. PubMed ID: 17695440
[TBL] [Abstract][Full Text] [Related]
14. Increased plasma DNA integrity in cancer patients.
Wang BG; Huang HY; Chen YC; Bristow RE; Kassauei K; Cheng CC; Roden R; Sokoll LJ; Chan DW; Shih IeM
Cancer Res; 2003 Jul; 63(14):3966-8. PubMed ID: 12873992
[TBL] [Abstract][Full Text] [Related]
15. Diagnostic role of circulating free plasma DNA detection in patients with localized prostate cancer.
Altimari A; Grigioni AD; Benedettini E; Gabusi E; Schiavina R; Martinelli A; Morselli-Labate AM; Martorana G; Grigioni WF; Fiorentino M
Am J Clin Pathol; 2008 May; 129(5):756-62. PubMed ID: 18426736
[TBL] [Abstract][Full Text] [Related]
16. Quantification of circulating DNA in the plasma and serum of cancer patients.
Taback B; O'Day SJ; Hoon DS
Ann N Y Acad Sci; 2004 Jun; 1022():17-24. PubMed ID: 15251934
[TBL] [Abstract][Full Text] [Related]
17. Quantification of total plasma cell-free DNA in ovarian cancer using real-time PCR.
Kamat AA; Sood AK; Dang D; Gershenson DM; Simpson JL; Bischoff FZ
Ann N Y Acad Sci; 2006 Sep; 1075():230-4. PubMed ID: 17108216
[TBL] [Abstract][Full Text] [Related]
18. Integrity and Quantity of Total Cell-Free DNA in the Diagnosis of Thyroid Cancer: Correlation with Cytological Classification.
Salvianti F; Giuliani C; Petrone L; Mancini I; Vezzosi V; Pupilli C; Pinzani P
Int J Mol Sci; 2017 Jun; 18(7):. PubMed ID: 28672797
[TBL] [Abstract][Full Text] [Related]
19. Detection of mutated BRAFV600E variant in circulating DNA of stage III-IV melanoma patients.
Daniotti M; Vallacchi V; Rivoltini L; Patuzzo R; Santinami M; Arienti F; Cutolo G; Pierotti MA; Parmiani G; Rodolfo M
Int J Cancer; 2007 Jun; 120(11):2439-44. PubMed ID: 17315191
[TBL] [Abstract][Full Text] [Related]
20. Detection of circulating malignant cells by RT-PCR in long-term clinically disease-free I stage melanoma patients.
Baldi A; Dragonetti E; Battista T; Groeger AM; Esposito V; Baldi G; Santini D
Anticancer Res; 2000; 20(5C):3923-8. PubMed ID: 11268478
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]